Diffuse Lewy body disease is a neuropathological entity in which rounded eosinophilic inclusion bodies (Lewy bodies') are found within brainstem nuclei (in a manner identical to that which characterises idiopathic Parkinson's disease2) and throughout the cerebral cortex. Previous reports have described cases with progressive dementia, with or without psychiatric features, extrapyramidal syndromes, orthostatic hypotension and motor neuron disease."32 These reports have generally described single or small numbers of cases and may therefore give an unrepresentative view of the clinical features.
In an effort to broaden this perspective we describe the 15 cases ofdiffuse Lewy body disease identified in a systematic survey of all brains referred to this institution from one health district during a single year. unlikely that they were related to variations in levodopa levels (which, in any case, tend to occur over hours rather than days). 36 Three patients, all from the group presenting with Parkinson's disease, showed evidence of depression. Five patients, all from the groups presenting with dementia, had auditory or visual hallucinations or delusions with paranoid content.
Discussion
The literature on diffuse Lewy body disease has grown steadily since the first two cases were described by Incidence ofdiffuse Lewy body disease The increasing frequency of reports of diffuse Lewy Byrne, Lennox, Lowe, Godwin-Austen body disease almost certainly reflects improving neuropathological recognition rather than a true increase in incidence. It is a condition that is easily overlooked, unless specifically sought. By the systematic use of routine H&E stains we have identified 15 cases from a limited population in a single year. A retrospective post-mortem series such as this is inevitably subject to bias; in particular, post-mortem examinations are more likely to be requested on hospital inpatients (who tend to be elderly and heavily dependent) and the clinically puzzling. The series is especially likely to underestimate of the incidence of diffuse Lewy body disease in young patients who are often cared for at home by their fit spouses. Despite these limitations, the fact that 15 cases of diffuse Lewy body disease were identified within a limited population in a single year suggests that the disease is not as rare as the literature would suggest.
Range ofclinicalfeatures This study documents for the first time the clinical features of a large and systematic series of cases of diffuse Lewy body disease. None of the clinical features described here is previously unreported, but many of them were much more common than one would expect from the literature (table 2) . To some extent these differences may reflect the brevity of many previous reports (for example, 11 of the 51 reports give no information regarding mode of presentation).
Presentation with Parkinsonianfeatures Few of the previously reported cases of diffuse Lewy body disease presented with symptoms or signs of Parkinson's disease. Ikeda et al " described a 30 year old man who presented with slight gait disturbance, bradykinesia and hypomimia, which worsened over six years to include generalised rigidity and slight tremor; there was a remarkable response to levodopa but the patient died suddenly aged 38. Kono et al'5 described a 55 year old woman who presented with dizziness, hand tremor and bradykinesia, and who subsequently developed rigidity, orthostatic hypotension and dementia; no trial oflevodopa is recorded. Sima et alP described a 72 year old woman who presented with Parkinsonism; she subsequently developed a spastic tetraparesis, emotional lability with intermittent aggression, bradykinesia and rigidity; levodopa produced little benefit. Finally Gibb et al'0 described a 33 year old woman who presented with depression and irritability but within a month developed left-sided tremor, rigidity and bradykinesia which was levodopa-responsive; she subsequently developed flexed posture, shuffling gait and progressive dementia with paranoid delusions and auditory hallucinations. These four cases constitute 8% of those in the previous literature. This contrasts 10 In this series the majority of patients (53%) experienced psychiatric disorder. Depression, which is thought to be common in Parkinson's disease, occurred in three cases and responded to conventional tricyclic antidepressant treatment. Auditory and visual hallucinations, and paranoid ideation (often accompanied by aggressive behaviour) occurred in a further five cases; it was more difficult to manage, because conventional dopamine antagonist treatment produced marked deterioration in extrapyramidal function.
Conclusions
Although a retrospective survey of this type cannot give accurate information regarding prevalence, it suggests that diffuse Lewy body disease is not rare. It confirms that diffuse Lewy body disease presents in a variety of ways, with a spectrum ranging from a Parkinsonian syndrome with subsequent dementia to dementia with a subsequent Parkinsonian syndrome. It suggests that the former mode of presentation, indistinguishable from idiopathic Parkinson's disease in clinical features and levodopa-response, may be far commoner than has previously been realised, and thus that diffuse Lewy body disease may be a significant cause ofdementia in Parkinson's disease. It shows that the latter mode of presentation, with "extrapyramidal dementia", is also common in diffuse Lewy body disease; the disease must be considered in the differential diagnosis of such cases, especially in assessing differences in prognosis in prospective clinical studies of dementia. Finally, it shows that the dementia ofdiffuse Lewy body disease generally shows cortical features, and may fluctuate in severity from day-to-day.
We hope that these observations will stimulate further research into this poorly-understood pathological entity. A prospective clinicopathological study, conducted by neuropathologists familiar with the appearances of diffuse Lewy body disease, is now required to establish its place amongst the other, more established, causes of dementia with extrapyramidal features and in particular to determine the frequency with which it forms the pathological basis of the common and important problem of dementia in Parkinson's disease.
